추천 제품
일반 설명
Our monodisperse non-porous silica particles have a uniform particle size of 40 µm and a narrow size distribution. Furthermore, these particles are non-porous, meaning they do not contain any internal void spaces. This feature renders their surfaces impermeable to fluids and gases. Additionally, their monodispersity contributes to excellent dispersion properties, allowing them to disperse evenly and maintain stability in a range of solvents, suspensions, or matrices.
애플리케이션
Monodispersed non-porous silica particles find use in various applications such as fillers or additives in composites, coatings, paints, and polymers to enhance mechanical properties or provide unique functionalities. Additionally, these particles find utility in diagnostics, drug delivery systems, sensors, catalysis, and environmental remediation. Their tailored size, uniformity, and stable surfaces contribute to their effectiveness in these applications. The silica particle surface exhibits a highly modifiable chemistry that allows for easy passive functionalization with a variety of biomolecules. The silica particles can also be modified with different functional groups, which can serve as a scaffold for the covalent attachment of biological components such as dextran, antibodies, DNA, or peptides.,
Storage Class Code
11 - Combustible Solids
WGK
nwg
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
Ja-Yeon Kim et al.
Scientific reports, 7(1), 14566-14566 (2017-11-08)
Nonporous silica nanoparticles (SiNPs) are promising drug carrier platforms for intraocular drug delivery. In this study, we investigated the safety of three different sizes of SiNPs (50, 100, and 150 nm) in a human corneal endothelial cell (HCEC) line, B4G12. The
Sean E Lehman et al.
Langmuir : the ACS journal of surfaces and colloids, 32(3), 731-742 (2015-12-31)
Understanding complex chemical changes that take place at nano-bio interfaces is of great concern for being able to sustainably implement nanomaterials in key applications such as drug delivery, imaging, and environmental remediation. Typical in vitro assays use cell viability as
Li Tang et al.
Nano today, 8(3), 290-312 (2013-09-03)
Nanomedicine, the use of nanotechnology for biomedical applications, has potential to change the landscape of the diagnosis and therapy of many diseases. In the past several decades, the advancement in nanotechnology and material science has resulted in a large number
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.